Listen to Raman as he recaps the standout episodes, guest speakers, and impactful moments that defined 2024:
First and foremost, the entire team at Molecule to Market would like to thank all of our dedicated listeners for your incredible support throughout 2024.
This year has been one for the books, filled with engaging conversations, groundbreaking topics, and inspiring guests from across the pharma services space.
We’ve had the privilege of speaking to some of the most innovative minds, spotlighting leaders who are shaping the future of drug development, embracing cutting-edge AI, advancing innovative therapeutics, and breaking barriers in what is often a male-dominated industry.
Through our Women in Science series, we proudly showcased powerful female leaders driving change and paving the way forward.
Key highlights from 2024:
- Global reach: 97 countries tuned in
- New series: Tasty Topics & Women in Science launched
- Exceptional guests: 28 CEOs shared their insights
- Streamed minutes: Over 1M+ minutes listened
- Milestone episodes: 199 episodes and counting
Powerful conversations
We’ve spotlighted trailblazers like Denise Bowser, Rani Powers, and Camila Easter while exploring hot topics like AI, GLP-1 treatments, the BIOSECURE Act, and industry-shifting acquisitions.
Leaders like Bill Humphries and Peter Stevenson joined us to share their expertise in the evolving CDMO landscape, and we continued to highlight emerging trends and opportunities shaping the sector.
What’s next?
As we gear up for 2025, we’re excited to kick off the year with a very special milestone: Episode 200, launching January 3rd, 2025. We can’t wait to bring you even more inspiring stories and transformative industry insights in the year ahead.
Thank you again for being part of this incredible journey. Here’s to another groundbreaking year ahead with Molecule to Market!